CardiaTec Biosciences
Decoding cardiovascular disease with AI
- Headquarters
- Munich
- Business Model
- B2B
- Website
- cardiatec.ai
- Total Funding
- $8.2M
- Last Round
- $6.5M SeedSep 2024
About
CardiaTec is a TechBio company leveraging multiomics data from human cardiac tissue to discover novel cardiovascular therapeutics. The company builds the largest human cardiac tissue multiomics database through partnerships with 65+ hospitals across the US and UK, using advanced computational modeling and AI to unravel disease mechanisms and discover drug targets.
Tech Stack
Computational Modeling
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account